Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Pulmonary Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added…
DUBLIN–(BUSINESS WIRE)–The “Cancer Therapeutics and Supportive Care Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025”…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global Addison’s disease therapeutics market is expected to post a CAGR of close to 4% during…
NEW YORK–(BUSINESS WIRE)–Ichor Biologics received a $300,000 grant from the National Institutes of Health to utilize its platform technology to…
ACC is a rare form of malignant cancer with limited treatment options available Investigational new drug AL101 is in Phase…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/INDstatus?src=hash" target="_blank"gt;#INDstatuslt;/agt;–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for…
The traditional R&D in the biopharmaceutical industry iswitnessing an upsurge, due to drug development research, which ishelping in the augmentation of the industrial microbiology market.
Celgene plans additional studies with the AIDS Malignancy Consortiumin U.S. and sub-Saharan Africa
Sesen bio to use the most recent analysis of its 12-monthPhase 3 VISTA trial data, which will be the basis for the meetings withthe FDA in May and June.
Acerus posts total revenues in Q1-2019 of $2.2 million, an increase of $0.5 millionor 33% compared to the first quarter of 2018 (“Q1-2018”).